NEW YORK CITY, NY / ACCESS Newswire / December 26, 2025 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Primo Brands Corporation / Primo Water Corporation (NYSE:PRMB) securities. If you suffered a loss on your Primo Brands Corporation / […]

NEW YORK CITY, NY / ACCESS Newswire / December 26, 2025 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Inspire Medical Systems, Inc. (NYSE:INSP) securities. If you suffered a loss on your Inspire Medical Systems, Inc. investment and would

NEW YORK CITY, NY / ACCESS Newswire / December 26, 2025 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired CarMax, Inc. (NYSE:KMX) securities. If you suffered a loss on your CarMax, Inc. investment and would like to explore a

NEW YORK CITY, NY / ACCESS Newswire / December 26, 2025 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Telix Pharmaceuticals Ltd. (NASDAQ:TLX) securities. If you suffered a loss on your Telix Pharmaceuticals Ltd. investment and would like to

NEW YORK CITY, NY / ACCESS Newswire / December 26, 2025 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired DeFi Technologies (NASDAQ:DEFT) securities. If you suffered a loss on your DeFi Technologies investment and would like to explore a

NEW YORK CITY, NY / ACCESS Newswire / December 26, 2025 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Freeport-McMoRan Inc. (NYSE:FCX) securities. If you suffered a loss on your Freeport-McMoRan Inc. investment and would like to explore a

NEW YORK CITY, NY / ACCESS Newswire / December 26, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Anavex and certain of its officers

NEW YORK CITY, NY / ACCESS Newswire / December 26, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Live Oak Bancshares, Inc. ("Live Oak" or the "Company") (NYSE:LOB). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Live Oak and certain of

NEW YORK CITY, NY / ACCESS Newswire / December 26, 2025 / Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. ("PetMed" or the "Company") (NASDAQ:PETS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether PetMed and certain of its officers and/or

NEW YORK CITY, NY / ACCESS Newswire / December 26, 2025 / Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. ("agilon" or the "Company") (NYSE:AGL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether agilon and certain of its officers and/or